Healthcare provider profile · identity verified

Kelly Fox, NP

Nurse Practitioner · ECKERT, CO · NPI 1891119939

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	379	43
Potassium Chloride	Potassium Chloride	315	33
Levothyroxine Sodium	Levothyroxine Sodium	289	34
Pantoprazole Sodium	Pantoprazole Sodium	264	28
Metoprolol Succinate	Metoprolol Succinate	237	22
Furosemide	Furosemide	198	24
Lisinopril	Lisinopril	149	18
Gabapentin	Gabapentin	148	18
Trazodone Hcl	Trazodone Hcl	146	15
Oxycodone Hcl	Oxycodone Hcl	144	18
Sertraline Hcl	Sertraline Hcl	140	14
Amlodipine Besylate	Amlodipine Besylate	138	14
Eliquis	Apixaban	127	13
Omeprazole	Omeprazole	120	14
Metformin Hcl	Metformin Hcl	113	14
Lorazepam	Lorazepam	107	20
Tamsulosin Hcl	Tamsulosin Hcl	106	11
Metoprolol Tartrate	Metoprolol Tartrate	104	11
Rosuvastatin Calcium	Rosuvastatin Calcium	104	11
Pravastatin Sodium	Pravastatin Sodium	93	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	92	16
Duloxetine Hcl	Duloxetine Hcl	91	15
Escitalopram Oxalate	Escitalopram Oxalate	91	11
Quetiapine Fumarate	Quetiapine Fumarate	85	suppressed
Famotidine	Famotidine	83	12
Clopidogrel	Clopidogrel Bisulfate	81	suppressed
Latanoprost	Latanoprost	80	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	77	12
Hydrochlorothiazide	Hydrochlorothiazide	76	12
Torsemide	Torsemide	74	suppressed
Losartan Potassium	Losartan Potassium	67	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	64	suppressed
Nystatin	Nystatin	63	26
Xarelto	Rivaroxaban	61	suppressed
Meloxicam	Meloxicam	57	suppressed
Glipizide	Glipizide	55	suppressed
Ropinirole Hcl	Ropinirole Hcl	55	suppressed
Aripiprazole	Aripiprazole	51	suppressed
Bupropion Xl	Bupropion Hcl	49	suppressed
Dapagliflozin	Dapagliflozin Propanediol	49	suppressed
Tramadol Hcl	Tramadol Hcl	49	suppressed
Mirtazapine	Mirtazapine	48	suppressed
Pregabalin	Pregabalin	48	suppressed
Olanzapine	Olanzapine	47	suppressed
Fentanyl	Fentanyl	46	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	44	18
Alendronate Sodium	Alendronate Sodium	44	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	43	suppressed
Carvedilol	Carvedilol	41	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	41	suppressed
Myrbetriq	Mirabegron	39	suppressed
Simvastatin	Simvastatin	39	suppressed
Mirabegron Er	Mirabegron	38	suppressed
Allopurinol	Allopurinol	36	suppressed
Primidone	Primidone	36	suppressed
Dexlansoprazole Dr	Dexlansoprazole	35	suppressed
Divalproex Sodium	Divalproex Sodium	34	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	33	suppressed
Clonazepam	Clonazepam	32	suppressed
Fluticasone Propionate	Fluticasone Propionate	32	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	32	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Spironolactone	Spironolactone	30	suppressed
Irbesartan	Irbesartan	28	suppressed
Lamotrigine	Lamotrigine	28	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Anastrozole	Anastrozole	27	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Divalproex Sodium Er	Divalproex Sodium	25	suppressed
Lurasidone Hcl	Lurasidone Hcl	25	suppressed
Trospium Chloride	Trospium Chloride	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	23	suppressed
Modafinil	Modafinil	23	suppressed
Tiotropium Bromide	Tiotropium Bromide	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Prolia	Denosumab	21	14
Acyclovir	Acyclovir	20	suppressed
Celecoxib	Celecoxib	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Risperidone	Risperidone	19	suppressed
Gemtesa	Vibegron	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Diazepam	Diazepam	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Digoxin	Digoxin	16	suppressed
Jardiance	Empagliflozin	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Timolol Maleate	Timolol Maleate	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Paliperidone Er	Paliperidone	14	suppressed
Phenobarbital	Phenobarbital	14	suppressed
Prednisone	Prednisone	14	suppressed
Travoprost	Travoprost	14	suppressed
Verapamil Sr	Verapamil Hcl	14	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	14	suppressed
Amlodipine-Valsartan-Hctz	Amlodipine/Valsartan/Hcthiazid	13	suppressed
Carvedilol Er	Carvedilol Phosphate	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Finasteride	Finasteride	13	suppressed
Flecainide Acetate	Flecainide Acetate	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Lactulose	Lactulose	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Methimazole	Methimazole	13	suppressed
Montelukast Sodium	Montelukast Sodium	13	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	13	suppressed
Xifaxan	Rifaximin	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Icosapent Ethyl	Icosapent Ethyl	12	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Carospir	Spironolactone	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	11	suppressed
Estradiol	Estradiol	11	suppressed
Febuxostat	Febuxostat	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error